Therefore, the risk of adverse events related to vasoconstriction (hypertension, headache, and stroke) which may be associated with S1PR3 was predicted to be low (Willis and Cohen, 2013; Camm et al., 2014; Stepanovska et al., 2020). Here, S1PR3 is linked to Hypertension.